NEOG Neogen Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEOG

Price (delayed)

$8.885

Market cap

$1.93B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.8

Enterprise value

$2.57B

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 20
Relative Profitability: Rel. Profitability: 20

NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural ...

Highlights
The debt is down by 11% year-on-year
The quick ratio is up by 4.2% since the previous quarter but it is down by 3.4% year-on-year
The EPS is down by 26% year-on-year
Neogen's net income has decreased by 25% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neogen.com
Peers: IDXX ILMN TMO PACB

Key stats

What are the main financial stats of NEOG

NEOG stock price

How has the Neogen stock price performed over time
Intraday
-0.39%
1 week
-4.56%
1 month
-0.17%
1 year
86.27%
YTD
27.11%
QTD
-4.36%

Financial performance

How have Neogen's revenue and profit performed over time
Revenue
$870.54M
Gross profit
$393.51M
Operating income
-$635.95M
Net income
-$608.78M
Gross margin
45.2%
Net margin
-69.9%
The operating margin has dropped by 52% year-on-year and by 2.5% since the previous quarter
The company's operating income fell by 46% YoY
The net margin is down by 30% year-on-year and by 2% since the previous quarter
Neogen's net income has decreased by 25% YoY

Price vs fundamentals

How does NEOG's price correlate with its fundamentals

Growth

What is Neogen's growth rate over time

Valuation

What is Neogen stock price valuation
NEOG P/E details
P/E
N/A
P/B
0.92
P/S
2.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.95
The EPS is down by 26% year-on-year
The P/B is 49% less than the 5-year quarterly average of 1.8 but 31% more than the last 4 quarters average of 0.7
Neogen's equity has decreased by 21% YoY
The price to sales (P/S) is 49% lower than the 5-year quarterly average of 4.4 but 24% higher than the last 4 quarters average of 1.8
The revenue has contracted by 3.9% YoY

Efficiency

How efficient is Neogen business performance
Neogen's return on equity has shrunk by 74% YoY and by 8% QoQ
The ROA has dropped by 59% year-on-year and by 6% since the previous quarter
The ROS is down by 35% year-on-year and by 3.7% since the previous quarter
The return on invested capital has declined by 33% year-on-year and by 4.3% since the previous quarter

Dividends

What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEOG.

Financial health

How did Neogen financials performed over time
The total assets is 167% more than the total liabilities
The total assets has contracted by 17% YoY
The total liabilities is down by 9% year-on-year
The debt is 62% smaller than the equity
Neogen's equity has decreased by 21% YoY
The company's debt to equity rose by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.